9578 Federal Register / Vol. 76, No. 34 / Friday, February 18, 2011 / Notices 

Dated: February 14, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–3710 Filed 2–17–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Environmental 

Health/Agency for Toxic Substances 

and Disease Registry (NCEH/ATSDR); 

Notice of National Conversation on 

Public Health and Chemical Exposures 

Leadership Council Meeting 

Time and Date: 8:30 a.m.–5 p.m., 

Friday, March 11, 2011. 

Location: Washington Plaza Hotel, 10 

Thomas Circle, NW., Washington, DC 

20005. 

Status: Open to the public, on a first 

come, first served basis, limited by the 

space available. An opportunity for the 

public to listen to the meeting by phone 

may be provided; see ‘‘contact for 

additional information’’ below. 

Purpose: This is the final scheduled 

meeting of the National Conversation on 

Public Health and Chemical Exposures 

Leadership Council. The National 

Conversation on Public Health and 

Chemical Exposures is a collaborative 

initiative through which many 

organizations and individuals are 

helping develop an action agenda for 

strengthening the nation’s approach to 

protecting the public’s health from 

harmful chemical exposures. The 

Leadership Council provides overall 

guidance to the National Conversation 

project and will be responsible for 

issuing the final action agenda. For 

additional information on the National 

Conversation on Public Health and 

Chemical Exposures, visit this Web site: 

http://www.atsdr.cdc.gov/ 

nationalconversation/. 

Meeting agenda: The Leadership 

Council will finalize the Action Agenda. 

Contact for additional information: If 

you would like to receive additional 

information on attending the meeting or 

the potential opportunity to listen to the 

meeting by phone, please contact: 

nationalconversation@cdc.gov or Julie 

Fishman at 770–488–0629. 

Dated: February 9, 2011. 

Tanja Popovic, 

Deputy Associate Director for Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2011–3654 Filed 2–17–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Conducting 

Public Health Research Through the 

Field Epidemiology and Laboratory 

Training Programs (FETPs/FELTPs), 

Funding Opportunity Announcement 

(FOA) GH11–001, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12:30 p.m.–3 p.m., April 

13, 2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Conducting Public Health 

Research Through the Field Epidemiology 

and Laboratory Training Programs (FETPs/ 

FELTPs), FOA GH11–001, initial review.’’ 

Contact Person for More Information: 

Diana Bartlett, M.P.H., Scientific Review 

Officer, CDC, 1600 Clifton Road, N.E., MS– 

D72 (attn: Christine Morrison), Atlanta, 

Georgia 30333, Telephone: (404) 639–4938, 

E-mail dbartlett@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 14, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–3709 Filed 2–17–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): National Spina 

Bifida Patient Registry—Clinic 

Demonstration Project (U01), Funding 

Opportunity Announcement (FOA) 

DD11–001, Initial Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 1 p.m.–4 p.m., March 31, 

2011 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of the ‘‘National Spina Bifida 

Patient Registry—Clinic Demonstration 

Project (U01), FOA DD11–001, initial 

review.’’ 

Contact Person for More Information: 

Hylan D. Shoob, PhD, M.S.P.H., Scientific 

Review Officer, Office of the Associate 

Director for Science, Office of the Director, 

CDC, 1600 Clifton Road, NE., Mailstop D–72, 

Atlanta, GA 30333, Telephone: (404) 639– 

4796, E-mail: hshoob@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 14, 2011. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2011–3708 Filed 2–17–11; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Clinical Laboratory Improvement 

Advisory Committee 

Correction: This notice was published 

in the Federal Register on January 31, 

2011, Volume 76, Number 20, page 

5379. The location of the meeting has 

changed as follows: 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES